Robert C. Doebele, M.D., Ph.D. is currently the Chief Medical Officer at Boundless Bio, specializing in lung and other thoracic malignancies. They co-founded Rain Oncology and Stratus Therapeutics, where they contributed to the development of precision oncology therapeutics. Previously, they served as a Director at the University of Colorado Cancer Center and held academic positions at the University of Chicago Medical Center and University of Colorado Anschutz Medical Campus. Robert's lab was instrumental in launching the TRK inhibitor field, leading to the approval of groundbreaking oncology drugs. They are also a Senior Editor for Clinical Cancer Research at AACR Journals.
This person is not in any teams
This person is not in any offices